Join NOW! :)

Alessandro Mannucci, MD a recipient of the 2023 #CGAIGC & Fight Colorectal Cancer Early Career Award, shares how the innovative #research funded by this grant has influenced his career.  Learn more about this grant & the other two grants available here 👉cgaigc.com/grant-opportun… His journey serves as

From the very best, father of modern immunotherapy, Dr Steven A. Rosenberg. Trial # nct01174121 fightcolorectalcancer.org/clinical-trial… clinicaltrials.gov/study/NCT01174… #crc #colorectalcancer #crcsm

Protecting the progress in cancer care we’ve fought so hard - Anjee Davis Fight Colorectal Cancer AnjeeDavis oncodaily.com/blog/anjee-dav… #Cancer #Oncology #OncoDaily #Health #Medicine #MedEd #MedX #MedNews

Despite recent breakthroughs in cancer immunotherapy research, The Washington Post details, 2020 AACR-CRI Lloyd J. Old Award recipient Dr. Rosenberg of NIH "has never seen anything like the turmoil outside his lab, which is beginning to affect the science." yhoo.it/44gZ8i9

FDA approves a treatment for patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer fda.gov/drugs/resource…

It’s podcast launch day! The ImmunoVerse™️ is now streaming on all your favorite platforms! 🚀 I’m honored to kick off this new Moffitt Cancer Center podcast with the inaugural episode ft. Dr. Steven Rosenberg, my colleague, friend, mentor and Chief of the Surgery Branch National Cancer Institute. In

At yesterday's opening ceremony, we asked the cancer community to stand together to make their voices heard in support of innovative cancer science and medicine. #CancerResearchSavesLives® #AACR25

These are the faces of cancer advocacy. TY AACR for creating programs & enabling opportunities for us to be here & be on the main stage of sessions. Cancer research saves lives when we all work together! #AACR25 Stacey Tinianov (she/her) MPH, BCPA Jill Feldman Bob Riter Kim Newcomer Manju George MVSc PhD Rectal Cancer Survivor

It's not only uncovering what is causing young-adult cases, but also how we can devise better ways to treat it. At today's #AACR25 session on Innovative Approaches to Key Molecular Targets, I will present work targeting a novel intracellular immune checkpoint using cell therapy.

Congratulations to our team. Next chapter in Nonoperative Management of Mismatch Repair–Deficient Tumors | New England Journal of Medicine nejm.org/doi/10.1056/NE…

Colorectal cancer doesn’t just impact one person—it affects everyone who loves them. That’s why this year, we’re inviting teams to apply for our Ambassador Program. Whether you're family, partners, or friends who’ve stood together through the fight, we want to hear your shared

Do you know an up-and-coming expert in the field of cancer #immunotherapy? Nominate them today for SITC’s Steven A. Rosenberg Scholars Award, one of the society's most prestigious opportunities for early career scientists. Learn more: sitcancer.org/Rosenberg-scho… #SITCForwardFund

🚨 URGENT: The President's 2026 Budget Proposal slashes cancer research and eliminates colorectal cancer screening programs. A proposed $18 BILLION CUT to NIH and elimination of the CDC's Colorectal Cancer Control Program puts lives at risk — especially in underserved communities

Colorectal cancer is on the rise among young adults, UC San Diego describes. New research has uncovered that DNA mutations arising during early childhood from a bacterial toxin called colibactin are a potential cause. Learn more: bit.ly/4lHv1GV #ColorectalCancer

Science tikkun: a bioscience pandemic framework in a Hebrew tradition of global repair | Molecular Medicine link.springer.com/article/10.118…

Anwaar Saeed presented DSP107 is a 1st in class T-cell engager with very promising activity in combo w/#immunotherapy including liver mets. #colorectalcancer #cancerresearch #cancer

🧬 Get ready for the latest in #colorectalcancer research! On June 10 at 11 AM EST, join us for Research Updates from ASCO 2025. Dr. Smitha Krishnamurthi and Annie Delores will break down the most exciting breakthroughs in CRC care. #ASCO25 Register to... fightcrc.zoom.us/webinar/regist…

Introducing ASCO Early-Onset/AYA Cancers Community of Practice, official twitter handle and logo. Please consider joining our CoP to advance care-delivery, research & education for pts with cancer in the EO/AYA groups. Looking forward to connecting with the community here on X!

Phase II Study of Anti-PD-1/​VEGF Bispecific Antibody Ivonescimab in Patients W/ Previously Treated Metastatic Colorectal Cancer MD Anderson Cancer Center PI: Saurav Haldar, MD NCT06959550, 90 pts trial recruiting date advanced from October 2025 to open up "early" in July 25 @SassyCell